0000914190-18-000294.txt : 20180719 0000914190-18-000294.hdr.sgml : 20180719 20180719171021 ACCESSION NUMBER: 0000914190-18-000294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180717 FILED AS OF DATE: 20180719 DATE AS OF CHANGE: 20180719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bove Mauro CENTRAL INDEX KEY: 0001396271 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 18960983 MAIL ADDRESS: STREET 1: C/O REGENERX BIOPHARMACEUTICALS, INC. STREET 2: 3 BETHESDA METRO CENTER - SUITE 630 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2018-07-17 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0001396271 Bove Mauro C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 0 0 0 Stock Option (right to buy) .28 2027-09-01 Common Stock 125000 125000 D Stock Option (Right to Buy) .21 2018-07-17 4 A 0 200000 .21 A 2028-07-17 Common Stock 200000 325000 D The option vests in four equal annual installments beginning on September 1, 2017. The option vests in four equal installments of 50,000 shares on each of July 17, 2018, 2019, 2020 and 2021. /s/ Andrew Nick as Attorney-in-Fact for Mauro Bove pursuant to Power of Attorney previously filed. 2018-07-19